Breast cancer. Nipple and areola, Central portion of breast, Upper-inner quadrant of breast, Lower-inner quadrant of breast, Upper-outer quadrant of breast, Lower-outer quadrant of breast, Axillary tail of breast, Overlapping lesion of breast, Breast, unspecified
Conditions
Interventions
Intervention 1: Interventional groups: 200 patients with breast cancer in stage 1 , 2 and 3 is finished surgery and adjuvant therapy, randomly selected and a Aspirin 80 mg is administered daily. Pati
Treatment - Drugs
Control group: 200 patients with breast cancer in stage 1 , 2 and 3 is finished surgery and adjuvant therapy, randomly selected and is not given any placebo. Patients are followed two years, and are c
Interventional groups: 200 patients with breast cancer in stage 1 , 2 and 3 is finished surgery and adjuvant therapy, randomly selected and a Aspirin 80 mg is administered daily. Patients are followe
Sponsors
Vice chancellor for research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Breast cancer patients in stage 1 , 2 and 3 and surgical and adjuvant treatments have been completed; Exclusion criteria: Patients who experience gastrointestinal problems and are sensitive to Aspirin are excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical examination. Timepoint: 2 years. Method of measurement: Clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mammography. Timepoint: 2 years. Method of measurement: Mammography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSedigheh Tahmasebi
Shiraz University of Medical Sciences
Outcome results
None listed